Albany International Reports Second-Quarter Results
Second-Quarter Financial Highlights
-
Net sales were
$172.3 million , a decrease of 11.0% compared to Q2 2014. Excluding currency effects, net sales decreased 5.6% (see Table 1). -
Including a charge of
$14.0 million for a revision in the estimated profitability of AEC’s BR725 contract, Adjusted EBITDA for Q2 2015 was$18.8 million , compared to$37.3 million in Q2 2014 (see Tables 6 and 7). -
Year-to-date net sales, excluding currency effects, increased 0.5%
compared to 2014 (see Table 8). Including the
$14.0 million charge, year-to-date Adjusted EBITDA was$60.3 million in 2015, compared to$75.0 million in 2014 (see Tables 9 and 10). -
Including the
$14.0 million charge ($0.28 per share), Q2 2015 income attributable to the Company was a loss of$0.07 per share. Earnings were reduced by restructuring charges of$0.02 , foreign currency revaluation losses of$0.04 , and income tax adjustments of$0.02 (see Tables 11 and 15). -
Q2 2014 income attributable to the Company was
$0.35 per share. Earnings were reduced by restructuring charges of$0.04 and income tax adjustments of$0.03 , and were increased by an insurance-recovery gain of$0.03 and foreign currency revaluation gains of$0.02 (see Tables 12 and 15).
As previously announced, the Company recorded a
Q2 2014 income before income taxes was
Table 1 summarizes net sales and the effect of changes in currency translation rates:
Table 1 |
||||||||||||||||||||
Impact of | ||||||||||||||||||||
Net Sales | Changes | Percent Change | ||||||||||||||||||
Three Months ended | in Currency | excluding | ||||||||||||||||||
|
June, | Percent | Translation |
Currency |
||||||||||||||||
(in thousands) |
2015 |
2014 |
Change |
Rates |
Rate Effect |
|||||||||||||||
Machine Clothing (MC) | $ | 150,561 | $ | 172,809 | -12.9 | % | ($9,970 | ) | -7.1 | % | ||||||||||
Albany Engineered Composites (AEC) | 21,728 | 20,709 | 4.9 | % | (403 | ) | 6.9 | % | ||||||||||||
Total | $ | 172,289 | $ | 193,518 | -11.0 | % | ($10,373 | ) | -5.6 | % | ||||||||||
Changes in currency translation rates, driven mainly by the stronger
U.S. dollar, resulted in a
Q2 2015 gross profit was
Selling, technical, general, and research (STG&R) expenses were
The following table presents expenses associated with internally funded research and development by segment:
Table 2 |
||||||||
Research and development | ||||||||
expenses by segment | ||||||||
Three Months ended | ||||||||
June 30, | ||||||||
(in thousands) |
2015 |
2014 |
||||||
Machine Clothing | $ | 4,779 | $ | 5,185 | ||||
Albany Engineered Composites | 2,905 | 2,267 | ||||||
Corporate expenses | 190 | 199 | ||||||
Total | $ | 7,874 | $ | 7,651 | ||||
The following table summarizes second-quarter operating income by segment:
Table 3 |
|||||||||||
|
Operating Income/(loss) Three Months ended June 30, |
||||||||||
(in thousands) |
2015 |
2014 |
|||||||||
Machine Clothing | $ | 33,323 | $ | 33,879 | |||||||
Albany Engineered Composites |
(18,633 |
) |
* |
(3,545 | ) | ||||||
Corporate expenses | (11,652 | ) | (11,357 | ) | |||||||
Total | $ | 3,038 | $ | 18,977 | |||||||
*Includes $14.0 million BR725 charge |
|||||||||||
Segment operating income was affected by restructuring, currency revaluation, and the BR725 charge as shown in Table 4 below.
Table 4 |
||||||||||||||||||||
Expenses/(gain) in Q2 2015 |
Expenses/(gain) in Q2 2014 | |||||||||||||||||||
resulting from |
resulting from | |||||||||||||||||||
(in thousands) |
Restructuring |
|
Revaluation |
|
BR725 Charge |
Restructuring |
|
|
Revaluation |
|||||||||||
Machine Clothing | $ | 1,211 | $ | 394 | $ | - | $ | 1,297 | $ | 350 | ||||||||||
Albany Engineered Composites | - | 1 | 14,000 | 660 | 61 | |||||||||||||||
Corporate expenses | - | 2 | - | - | 2 | |||||||||||||||
Total | $ | 1,211 | $ | 397 | $ | 14,000 | $ | 1,957 | $ | 413 | ||||||||||
Q2 2015 Other income/expense, net, was expense of
The following table summarizes currency revaluation effects on certain financial metrics:
Table 5 |
|||||||||
|
Income/(loss) attributable to currency revaluation Three Months ended June 30, |
||||||||
(in thousands) |
2015 |
2014 |
|||||||
Operating income | ($397 | ) | ($413 | ) | |||||
Other income/(expense), net | (1,878 | ) | 1,397 | ||||||
Total | ($2,275 | ) |
|
$984 |
|||||
The Company’s income tax rate, excluding tax adjustments, was 43.5% for
Q2 2015, compared to 36.5% for the same period of 2014. The higher tax
rate in Q2 2015 was due primarily to the impact of restructuring charges
where the Company is unable to record a tax benefit related to the
expense. Discrete tax charges and the effect of a change in the
estimated tax rate increased second-quarter income tax expense by
The following tables summarize Adjusted EBITDA:
Table 6 |
||||||||||||||||||
Three Months ended June 30, 2015 | Albany | Corporate | ||||||||||||||||
Machine | Engineered | expenses | Total | |||||||||||||||
(in thousands) |
Clothing | Composites | and other | Company | ||||||||||||||
Net income/(loss) | $ | 33,323 |
($18,633 |
) |
* |
($16,810 | ) | ($2,120 | ) | |||||||||
Interest expense, net | - | - | 2,702 | 2,702 | ||||||||||||||
Income tax expense/(benefit) | - | - | (364 | ) | (364 | ) | ||||||||||||
Depreciation and amortization | 10,212 | 2,869 | 2,103 | 15,184 | ||||||||||||||
EBITDA | 43,535 | (15,764 | ) | (12,369 | ) | 15,402 | ||||||||||||
Restructuring expenses, net | 1,211 | - | - | 1,211 | ||||||||||||||
Foreign currency revaluation (gains)/losses | 394 | 1 | 1,880 | 2,275 | ||||||||||||||
Pretax income attributable to noncontrolling interest in ASC | - | (64 | ) | - | (64 | ) | ||||||||||||
Adjusted EBITDA | $ | 45,140 | ($15,827 | ) | ($10,489 | ) | $ | 18,824 | ||||||||||
* Includes $14.0 million BR725 charge |
||||||||||||||||||
Table 7 |
|||||||||||||||||
Three Months ended June 30, 2014 | Albany | Corporate | |||||||||||||||
Machine | Engineered | expenses | Total | ||||||||||||||
(in thousands) |
Clothing | Composites | and other | Company | |||||||||||||
Net income | $ | 33,879 | ($3,545 | ) | ($19,157 | ) | $ | 11,177 | |||||||||
Interest expense, net | - | - | 2,717 | 2,717 | |||||||||||||
Income tax expense | - | - | 7,216 | 7,216 | |||||||||||||
Depreciation and amortization | 11,554 | 2,453 | 2,090 | 16,097 | |||||||||||||
EBITDA | 45,433 | (1,092 | ) | (7,134 | ) | 37,207 | |||||||||||
Restructuring expenses, net | 1,297 | 660 | - | 1,957 | |||||||||||||
Foreign currency revaluation losses/(gains) | 350 | 61 | (1,395 | ) | (984 | ) | |||||||||||
Gain on insurance recovery | - | - | (961 | ) | (961 | ) | |||||||||||
Pretax loss attributable to noncontrolling interest in ASC | - | 45 | - | 45 | |||||||||||||
Adjusted EBITDA | $ | 47,080 | ($326 | ) | ($9,490 | ) | $ | 37,264 | |||||||||
Capital spending was
CFO Comments
CFO and Treasurer
“Net debt (total debt less cash) increased
“Compared to currency rates in effect during Q2 2014, net sales were once again negatively impacted by the broadly stronger U.S. dollar while the impact on Adjusted EBITDA was somewhat positive. In the future, the currency impact on Adjusted EBITDA could be significantly different depending on the movement of the U.S. dollar against any of our key foreign currency net income or expense exposures.”
CEO Comments
President and CEO
“In MC, excluding currency effects, sales were down 7% compared to Q2
2014, primarily due to a sharply weaker market and lower sales in the
publication grades in
“Q2 Gross profit margins remained strong and well above Q2 2014 levels. This mitigated the impact of the weak sales on adjusted EBITDA, which declined 4% compared to Q2 2014 and which leaves year-to-date Adjusted EBITDA 1.5% ahead of the first half of 2014.
“We continued to make good progress during the quarter on the shift of sales mix away from publication grades. Meanwhile, in the development of our new technology platform, we ran successful trials with important customers in the tissue segment, scheduled initial trials in the packaging sector, and are seeing encouraging results from initial prototypes across all of our product lines.
“Turning to AEC, during Q2 we recorded a charge of
“In other respects, AEC performed well, and is firmly on track both for
our full-year forecast of 5-10% growth in sales and for the LEAP ramp
that begins late next year. The most important development this quarter
was the decision to build a third joint plant with
“As for R&D, this was a very encouraging quarter, with good progress on a number of potentially important airframe and engine projects, for both the near and long term. While significant uncertainties remain on all of them, several are approaching important development or commercialization decision points. Likewise, with Ricardo, we are actively engaged with a number of automotive OEMs in technical assessments of the viability of AEC technology for application in the high-performance, super-luxury segment of the automotive market. We expect to have developed a clear understanding of the near-term commercial viability of our technology for this market segment within the next six to twelve months.
“As mentioned above, our outlook for the full-year remains unchanged. We
continue to view macroeconomic uncertainties as the primary source of
downside risk to our outlook, and given recent developments in such key
growth markets as
“In sum, this was a weak quarter due primarily to lower MC sales in the
publication grades in
The Company plans a webcast to discuss second-quarter 2015 financial
results on
About
This release contains certain items, such as earnings before interest, taxes, depreciation and amortization (EBITDA), Adjusted EBITDA, sales excluding currency effects, income tax rate excluding adjustments, net debt, net income attributable to the Company, excluding adjustments (on an absolute and per-share basis), and certain income and expense items on a per-share basis that could be considered non-GAAP financial measures. Such items are provided because management believes that, when presented together with the GAAP items to which they relate, they provide additional useful information to investors regarding the Company’s operational performance. Presenting increases or decreases in sales, after currency effects are excluded, can give management and investors insight into underlying sales trends. An understanding of the impact in a particular quarter of specific restructuring costs, or other gains and losses, on operating income or EBITDA can give management and investors additional insight into quarterly performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. All non-GAAP financial measures in this release relate to the Company’s continuing operations.
The effect of changes in currency translation rates is calculated by converting amounts reported in local currencies into U.S. dollars at the exchange rate of a prior period. That amount is then compared to the U.S. dollar amount reported in the current period. The Company calculates Income tax adjustments by adding discrete tax items to the effect of a change in tax rate for the reporting period. The Company calculates its income tax rate, exclusive of income tax adjustments, by removing income tax adjustments from total Income tax expense, then dividing that result by Income before income taxes. The Company calculates EBITDA by removing the following from Net income: Interest expense net, Income tax expense, Depreciation and amortization, and Income or loss from Discontinued Operations. Adjusted EBITDA is calculated by: adding to EBITDA costs associated with restructuring and pension settlement charges; adding (or subtracting) revaluation losses (or gains); subtracting (or adding) gains (or losses) from the sale of buildings or investments; subtracting insurance recovery gains; and subtracting Income attributable to the noncontrolling interest in Albany Safran Composites (ASC). The Company believes that EBITDA and Adjusted EBITDA provide useful information to investors because they provide an indication of the strength and performance of the Company's ongoing business operations, including its ability to fund discretionary spending such as capital expenditures and strategic investments, as well as its ability to incur and service debt. While depreciation and amortization are operating costs under GAAP, they are noncash expenses equal to current period allocation of costs associated with capital and other long-lived investments made in prior periods.
While restructuring expenses, foreign currency revaluation losses or gains, pension settlement charges, insurance-recovery gains, and gains or losses from sales of buildings or investments have an impact on the Company's net income, removing them from EBITDA can provide, in the opinion of the Company, a better measure of operating performance. EBITDA is also a calculation commonly used by investors and analysts to evaluate and compare the periodic and future operating performance and value of companies. EBITDA, as defined by the Company, may not be similar to EBITDA measures of other companies. Such EBITDA measures may not be considered measurements under GAAP, and should be considered in addition to, but not as substitutes for, the information contained in the Company’s statements of income.
The Company discloses certain income and expense items on a per-share basis. The Company believes that such disclosures provide important insight into underlying quarterly earnings and are financial performance metrics commonly used by investors. The Company calculates the quarterly per-share amount for items included in continuing operations by using the estimated effective annual tax rate and the weighted average number of shares outstanding for each period. Year-to-date earnings per-share effects are determined by adding the amounts calculated at each reporting period.
Table 8 |
||||||||||||||||||||
|
Net Sales Six Months ended June, |
Percent |
Impact of Changes in Currency Translation |
Percent Change excluding Currency |
||||||||||||||||
(in thousands) |
2015 |
2014 |
Change |
Rates |
Rate Effect |
|||||||||||||||
Machine Clothing (MC) | $ | 309,055 | $ | 336,897 | -8.3 | % | ($21,287 | ) | -1.9 | % | ||||||||||
Albany Engineered Composites (AEC) | 44,558 | 36,928 | 20.7 | % | (740 | ) | 22.7 | % | ||||||||||||
Total | $ | 353,613 | $ | 373,825 | -5.4 | % | ($22,027 | ) | 0.5 | % | ||||||||||
Table 9 |
|||||||||||||||||||
Six Months ended June 30, 2015 | Albany | Corporate | |||||||||||||||||
Machine | Engineered | expenses | Total | ||||||||||||||||
(in thousands) |
Clothing | Composites | and other | Company | |||||||||||||||
Net income | $ | 69,013 |
($22,444 |
) |
* |
($36,450 | ) | $ | 10,119 | ||||||||||
Interest expense, net | - | - | 5,378 | 5,378 | |||||||||||||||
Income tax expense | - | - | 8,155 | 8,155 | |||||||||||||||
Depreciation and amortization | 20,416 | 5,865 | 4,257 | 30,538 | |||||||||||||||
EBITDA | 89,429 | (16,579 | ) | (18,660 | ) | 54,190 | |||||||||||||
Restructuring expenses, net | 10,212 | - | - | 10,212 | |||||||||||||||
Foreign currency revaluation losses/(gains) | (2,529 | ) | (17 | ) | (551 | ) | (3,097 | ) | |||||||||||
Gain on sale of investment | - | - | (872 | ) | (872 | ) | |||||||||||||
Pre-tax income attributable to noncontrolling interest in ASC |
- | (90 | ) | - | (90 | ) | |||||||||||||
Adjusted EBITDA | $ | 97,112 | ($16,686 | ) | ($20,083 | ) | $ | 60,343 | |||||||||||
*Includes $14 million BR725 charge |
|||||||||||||||||||
Table 10 |
|||||||||||||||||
Six Months ended June 30, 2014 | Albany | Corporate | |||||||||||||||
Machine | Engineered | expenses | Total | ||||||||||||||
(in thousands) |
Clothing | Composites | and other | Company | |||||||||||||
Net income | $ | 70,022 | ($7,021 | ) | ($41,131 | ) | $ | 21,870 | |||||||||
Interest expense, net | - | - | 5,635 | 5,635 | |||||||||||||
Income tax expense | - | - | 14,673 | 14,673 | |||||||||||||
Depreciation and amortization | 23,009 | 4,775 | 4,221 | 32,005 | |||||||||||||
EBITDA | 93,031 | (2,246 | ) | (16,602 | ) | 74,183 | |||||||||||
Restructuring expenses, net | 2,159 | 980 | - | 3,139 | |||||||||||||
Foreign currency revaluation losses/(gains) | 502 | 99 | (1,901 | ) | (1,300 | ) | |||||||||||
Gain on insurance recovery | - | - | (961 | ) | (961 | ) | |||||||||||
Pre-tax income attributable to noncontrolling interest in ASC | - | (13 | ) | - | (13 | ) | |||||||||||
Adjusted EBITDA | $ | 95,692 | ($1,180 | ) | ($19,464 | ) | $ | 75,048 | |||||||||
Table 11 |
||||||||||||||||
Three Months ended June 30, 2015 | ||||||||||||||||
|
Pre-tax | After-tax | Per Share | |||||||||||||
(in thousands, except per share amounts) |
amounts | Tax Effect | Effect | Effect | ||||||||||||
Restructuring and other, net | $ | 1,211 | $ | 448 | $ | 763 | $ | 0.02 | ||||||||
Foreign currency revaluation losses | 2,275 | 842 | 1,433 | 0.04 | ||||||||||||
Net discrete income tax benefit | - | 20 | 20 | 0.00 | ||||||||||||
Unfavorable effect of change in income tax rate | - | 736 | 736 | 0.02 | ||||||||||||
Charge for revision in estimated contract profitability | 14,000 | 5,180 | 8,820 | 0.28 | ||||||||||||
Table 12 |
||||||||||||||||
Three Months ended June 30, 2014 | ||||||||||||||||
Pre-tax | After-tax | Per Share | ||||||||||||||
(in thousands, except per share amounts) |
amounts | Tax Effect | Effect | Effect | ||||||||||||
Restructuring and other, net | $ | 1,957 | $ | 714 | $ | 1,243 | $ | 0.04 | ||||||||
Foreign currency revaluation gains | 984 | 359 | 625 | 0.02 | ||||||||||||
Gain on insurance recovery | 961 | - | 961 | 0.03 | ||||||||||||
Net discrete income tax charge | - | 569 | 569 | 0.02 | ||||||||||||
Unfavorable effect of change in income tax rate | - | 278 | 278 | 0.01 | ||||||||||||
Table 13 |
||||||||||||||||
Six Months ended June 30, 2015 | ||||||||||||||||
Pre-tax | After-tax | Per Share | ||||||||||||||
(in thousands, except per share amounts) |
amounts | Tax Effect | Effect | Effect | ||||||||||||
Restructuring and other, net | $ | 10,212 | $ | 3,868 | $ | 6,344 | $ | 0.20 | ||||||||
Foreign currency revaluation gains | 3,097 | 1,199 | 1,898 | 0.06 | ||||||||||||
Gain on sale of investment | 872 | 331 | 541 | 0.02 | ||||||||||||
Net discrete income tax charge | - | 199 | 199 | 0.01 | ||||||||||||
Charge for revision in estimated contract profitability | 14,000 | 5,180 | 8,820 | 0.28 | ||||||||||||
Table 14 |
||||||||||||||||
Six Months ended June 30, 2014 | ||||||||||||||||
Pre-tax | After-tax | Per Share | ||||||||||||||
(in thousands, except per share amounts) |
amounts | Tax Effect | Effect | Effect | ||||||||||||
Restructuring and other, net | $ | 3,139 | $ | 1,128 | $ | 2,011 | $ | 0.06 | ||||||||
Foreign currency revaluation gains | 1,300 | 469 | 831 | 0.03 | ||||||||||||
Gain on insurance recovery | 961 | - | 961 | 0.03 | ||||||||||||
Net discrete income tax charge | - | 1,673 | 1,673 | 0.05 | ||||||||||||
The following table contains the calculation of net income per share attributable to the Company, excluding adjustments:
Table 15 |
|||||||||||||||||||||
|
Three Months ended June 30, |
Six Months ended June 30, |
|||||||||||||||||||
Per share amounts (Basic) |
2015 |
2014 |
2015 |
2014 |
|||||||||||||||||
Net income/(loss) attributable to the Company, reported |
($0.07 |
) |
* |
$ | 0.35 |
$ |
0.31 |
* |
|
$ | 0.69 | ||||||||||
Adjustments: | |||||||||||||||||||||
Restructuring charges | 0.02 | 0.04 | 0.20 | 0.06 | |||||||||||||||||
Discrete tax charges and effect of change in income tax rate | 0.02 | 0.03 | 0.01 | 0.05 | |||||||||||||||||
Foreign currency revaluation (gains)/ losses | 0.04 | (0.02 | ) | (0.06 | ) | (0.03 | ) | ||||||||||||||
Gain on insurance recovery | - | (0.03 | ) | - | (0.03 | ) | |||||||||||||||
Gain on the sale of investment | - | - | (0.02 | ) | - | ||||||||||||||||
Net income attributable to the Company, excluding adjustments | $ | 0.01 | $ | 0.37 | $ | 0.44 | $ | 0.74 | |||||||||||||
*Includes $0.28 per share for BR725 charge |
|||||||||||||||||||||
The following table contains the calculation of net debt:
Table 16 |
||||||||||||||||||||||||||||
June 30, | March 31, | December 31, | September 30, | June 30, | March 31, | December 31, | ||||||||||||||||||||||
(in thousands) | 2015 | 2015 | 2014 | 2014 | 2014 | 2014 | 2013 | |||||||||||||||||||||
Notes and loans payable | $ | 543 | $ | 496 | $ | 661 | $ | 551 | $ | 692 | $ | 797 | $ | 625 | ||||||||||||||
Current maturities of long-term debt | 50,015 | 50,015 | 50,015 | 15 | 1,265 | 2,514 | 3,764 | |||||||||||||||||||||
Long-term debt | 252,088 | 232,092 | 222,096 | 283,100 | 283,104 | 299,108 | 300,111 | |||||||||||||||||||||
Total debt | 302,646 | 282,603 | 272,772 | 283,666 | 285,061 | 302,419 | 304,500 | |||||||||||||||||||||
Cash and cash equivalents | 182,474 | 170,838 | 179,802 | 195,461 | 206,836 | 208,379 | 222,666 | |||||||||||||||||||||
Net debt | $ | 120,172 | $ | 111,765 | $ | 92,970 | $ | 88,205 | $ | 78,225 | $ | 94,040 | $ | 81,834 | ||||||||||||||
This press release may contain statements, estimates, or projections that constitute “forward-looking statements” as defined under U.S. federal securities laws. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties (including, without limitation, those set forth in the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q) that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections.
Forward-looking statements in this release or in the webcast include,
without limitation, statements about macroeconomic and paper industry
trends and conditions during 2015 and in future years; expectations in
2015 and in future periods of sales, EBITDA, Adjusted EBITDA, income,
gross profit, gross margin and other financial items in each of the
Company’s businesses and for the Company as a whole; the timing and
impact of production and development programs in the Company’s AEC
business segment and AEC sales growth potential; the amount and timing
of capital expenditures, future tax rates and cash paid for taxes,
depreciation and amortization; future debt and net debt levels and debt
covenant ratios; the timeline for ASC’s planned facility in
Statements expressing management’s assessments of the growth potential of its businesses, or referring to earlier assessments of such potential, are not intended as forecasts of actual future growth, and should not be relied on as such. While management believes such assessments to have a reasonable basis, such assessments are, by their nature, inherently uncertain. This release and earlier releases set forth a number of assumptions regarding these assessments, including historical results, independent forecasts regarding the markets in which these businesses operate, and the timing and magnitude of orders for our customers’ products. Historical growth rates are no guarantee of future growth, and such independent forecasts and assumptions could prove materially incorrect, in some cases.
ALBANY INTERNATIONAL CORP. | ||||||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
June 30, | June 30, | |||||||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||||||
$ | 172,289 | $ | 193,518 | Net sales | $ | 353,613 | $ | 373,825 | ||||||||||||
117,697 | 118,175 | Cost of goods sold | 222,337 | 223,673 | ||||||||||||||||
54,592 | 75,343 | Gross profit | 131,276 | 150,152 | ||||||||||||||||
39,932 | 40,012 | Selling, general, and administrative expenses | 75,165 | 79,169 | ||||||||||||||||
10,411 | 14,397 | Technical, product engineering, and research expenses | 22,712 | 28,266 | ||||||||||||||||
1,211 | 1,957 | Restructuring expenses, net | 10,212 | 3,139 | ||||||||||||||||
3,038 | 18,977 | Operating income | 23,187 | 39,578 | ||||||||||||||||
2,702 | 2,717 | Interest expense, net | 5,378 | 5,635 | ||||||||||||||||
2,820 | (2,133 | ) | Other (income)/expenses, net | (465 | ) | (2,600 | ) | |||||||||||||
(2,484 | ) | 18,393 | Income/(loss) before income taxes | 18,274 | 36,543 | |||||||||||||||
(364 | ) | 7,216 | Income tax expense/(benefit) | 8,155 | 14,673 | |||||||||||||||
(2,120 | ) | 11,177 | Net income/(loss) | 10,119 | 21,870 | |||||||||||||||
52 | (42 | ) | Net income/(loss) attributable to the noncontrolling interest | 78 | 30 | |||||||||||||||
($2,172 | ) | $ | 11,219 | Net income/(loss) attributable to the Company | $ | 10,041 | $ | 21,840 | ||||||||||||
($0.07 | ) | $ | 0.35 | Earnings/(losses) per share attributable to Company shareholders - Basic | $ | 0.31 | $ | 0.69 | ||||||||||||
($0.07 | ) | $ | 0.35 | Earnings(losses) per share attributable to Company shareholders - Diluted | $ | 0.31 | $ | 0.68 | ||||||||||||
Shares of the Company used in computing earnings per share: | ||||||||||||||||||||
31,999 | 31,832 | Basic | 31,941 | 31,809 | ||||||||||||||||
31,999 | 31,935 | Diluted | 32,015 | 31,913 | ||||||||||||||||
$ | 0.17 | $ | 0.16 | Dividends per share | $ | 0.33 | $ | 0.31 | ||||||||||||
ALBANY INTERNATIONAL CORP. | ||||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||||
(in thousands, except share data) | ||||||||||
(unaudited) | ||||||||||
June 30, | December 31, | |||||||||
2015 | 2014 | |||||||||
ASSETS | ||||||||||
Cash and cash equivalents | $ | 182,474 | $ | 179,802 | ||||||
Accounts receivable, net | 160,997 | 158,237 | ||||||||
Inventories | 109,630 | 107,274 | ||||||||
Deferred income taxes | 6,661 | 6,743 | ||||||||
Asset held for sale | 8,326 | 9,102 | ||||||||
Prepaid expenses and other current assets | 8,739 | 8,074 | ||||||||
Total current assets | 476,827 | 469,232 | ||||||||
Property, plant and equipment, net | 379,139 | 386,011 | ||||||||
Intangibles | 270 | 385 | ||||||||
Goodwill | 67,489 | 71,680 | ||||||||
Income taxes receivable and deferred | 71,817 | 69,540 | ||||||||
Other assets | 27,905 | 32,456 | ||||||||
Total assets | $ | 1,023,447 | $ | 1,029,304 | ||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||
Notes and loans payable | $ | 543 | $ | 661 | ||||||
Accounts payable | 32,258 | 34,787 | ||||||||
Accrued liabilities | 89,544 | 95,149 | ||||||||
Current maturities of long-term debt | 50,015 | 50,015 | ||||||||
Income taxes payable and deferred | 1,742 | 2,786 | ||||||||
Total current liabilities | 174,102 | 183,398 | ||||||||
Long-term debt | 252,088 | 222,096 | ||||||||
Other noncurrent liabilities | 98,589 | 103,079 | ||||||||
Deferred taxes and other credits | 6,783 | 7,163 | ||||||||
Total liabilities | 531,562 | 515,736 | ||||||||
SHAREHOLDERS' EQUITY | ||||||||||
Preferred stock, par value $5.00 per share; | ||||||||||
authorized 2,000,000 shares; none issued | - | - | ||||||||
Class A Common Stock, par value $.001 per share; | ||||||||||
authorized 100,000,000 shares; issued 37,230,013 | ||||||||||
in 2015 and 37,085,489 in 2014 | 37 | 37 | ||||||||
Class B Common Stock, par value $.001 per share; | ||||||||||
authorized 25,000,000 shares; issued and | ||||||||||
outstanding 3,235,048 in 2015 and 2014 | 3 | 3 | ||||||||
Additional paid in capital | 422,204 | 418,972 | ||||||||
Retained earnings | 455,597 | 456,105 | ||||||||
Accumulated items of other comprehensive income: | ||||||||||
Translation adjustments | (81,263 | ) | (55,240 | ) | ||||||
Pension and postretirement liability adjustments | (50,056 | ) | (51,666 | ) | ||||||
Derivative valuation adjustment | (1,024 | ) | (861 | ) | ||||||
Treasury stock (Class A), at cost 8,455,293 shares | ||||||||||
in 2015 and 8,459,498 in 2014 | (257,391 | ) | (257,481 | ) | ||||||
Total Company shareholders' equity | 488,107 | 509,869 | ||||||||
Noncontrolling interest | 3,778 | 3,699 | ||||||||
Total equity | 491,885 | 513,568 | ||||||||
Total liabilities and shareholders' equity | $ | 1,023,447 | $ | 1,029,304 | ||||||
ALBANY INTERNATIONAL CORP. | |||||||||||||||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOW | |||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||
(unaudited) | |||||||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||
2015 | 2014 | 2015 | 2014 | ||||||||||||||||||||
|
OPERATING ACTIVITIES |
||||||||||||||||||||||
($2,120 | ) | $ | 11,177 |
|
Net income/(loss) |
$ | 10,119 | $ | 21,870 | ||||||||||||||
|
Adjustments to reconcile net income/(loss) to net cash provided by operating activities: |
||||||||||||||||||||||
13,373 | 14,276 | Depreciation | 26,897 | 28,383 | |||||||||||||||||||
1,811 | 1,821 | Amortization | 3,641 | 3,622 | |||||||||||||||||||
(5,920 | ) | 2,946 | Change in long-term liabilities, deferred taxes and other credits | (6,197 | ) | 2,732 | |||||||||||||||||
263 | 728 | Provision for write-off of property, plant and equipment | 415 | 729 | |||||||||||||||||||
- | (961 | ) | Gain on disposition or involuntary conversion of assets | (1,056 | ) | (961 | ) | ||||||||||||||||
(342 | ) | (106 | ) | Excess tax benefit of options exercised | (603 | ) | (145 | ) | |||||||||||||||
419 | 405 | Compensation and benefits paid or payable in Class A Common Stock | 995 | 947 | |||||||||||||||||||
|
Changes in operating assets and liabilities that provide/(use) cash: |
||||||||||||||||||||||
4,212 | 3,333 | Accounts receivable | (9,487 | ) | 14,297 | ||||||||||||||||||
(4,061 | ) | (1,963 | ) | Inventories | (7,131 | ) | (10,959 | ) | |||||||||||||||
1,715 | 1,762 | Prepaid expenses and other current assets | (990 | ) | (386 | ) | |||||||||||||||||
(158 | ) | (7 | ) | Income taxes prepaid and receivable | (74 | ) | 14 | ||||||||||||||||
(4,853 | ) | 555 | Accounts payable | (1,341 | ) | (739 | ) | ||||||||||||||||
(933 | ) | 170 | Accrued liabilities | (2,520 | ) | (12,679 | ) | ||||||||||||||||
475 | 651 | Income taxes payable | 77 | (1,059 | ) | ||||||||||||||||||
7,062 | (2,098 | ) | Other, net | 4,607 | (4,129 | ) | |||||||||||||||||
10,943 | 32,689 | Net cash provided by operating activities | 17,352 | 41,537 | |||||||||||||||||||
|
INVESTING ACTIVITIES |
||||||||||||||||||||||
(18,455 | ) | (12,799 | ) | Purchases of property, plant and equipment | (30,666 | ) | (27,402 | ) | |||||||||||||||
(304 | ) | (21 | ) | Purchased software | (337 | ) | (315 | ) | |||||||||||||||
- | 961 | Proceeds from sale or involuntary conversion of assets | 2,797 | 961 | |||||||||||||||||||
(18,759 | ) | (11,859 | ) | Net cash used in investing activities | (28,206 | ) | (26,756 | ) | |||||||||||||||
|
FINANCING ACTIVITIES |
||||||||||||||||||||||
24,346 | 235 | Proceeds from borrowings | 39,620 | 4,670 | |||||||||||||||||||
(4,303 | ) | (17,593 | ) | Principal payments on debt | (9,746 | ) | (24,109 | ) | |||||||||||||||
(1,630 | ) | - | Debt acquisition costs | (1,630 | ) | - | |||||||||||||||||
1,039 | 261 | Proceeds from options exercised | 1,724 | 387 | |||||||||||||||||||
342 | 106 | Excess tax benefit of options exercised | 603 | 145 | |||||||||||||||||||
(5,107 | ) | (4,774 | ) | Dividends paid | (10,205 | ) | (9,539 | ) | |||||||||||||||
14,687 | (21,765 | ) | Net cash provided by/(used in) financing activities | 20,366 | (28,446 | ) | |||||||||||||||||
|
|||||||||||||||||||||||
4,765 | (608 | ) |
|
Effect of exchange rate changes on cash and cash equivalents |
(6,840 | ) | (2,165 | ) | |||||||||||||||
11,636 | (1,543 | ) |
|
Increase/(decrease) in cash and cash equivalents |
2,672 | (15,830 | ) | ||||||||||||||||
170,838 | 208,379 |
|
Cash and cash equivalents at beginning of period |
179,802 | 222,666 | ||||||||||||||||||
$ | 182,474 | $ | 206,836 |
|
Cash and cash equivalents at end of period |
$ | 182,474 | $ | 206,836 |
View source version on businesswire.com: http://www.businesswire.com/news/home/20150804006931/en/
Source:
Albany International Corp.
Investors
John Cozzolino,
518-445-2281
john.cozzolino@albint.com
or
Media
Susan
Siegel, 603-330-5866
susan.siegel@albint.com